Molecular Matrix, a privately held company that arose from the University of California, Davis, received FDA approval for its Osteo-P bone graft substitute technology. Osteo-P is a non-mineralized, ...
BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, announces that ...
WESTMINSTER, Colo., Dec. 17, 2025 /PRNewswire/ -- Cerapedics Inc., a global, commercial-stage orthopedics company dedicated to redefining the path to bone repair, today announced the publication of ...
Each year, about 2.2 million bone-grafting procedures are performed worldwide, the gold standard of care being autografting, which uses the patient's own bone for tooth implantation and to repair and ...
BURLINGTON, Mass.--(BUSINESS WIRE)-- Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, reports progress with advancing its product candidate ...
Morning Overview on MSN
Graphene scaffold recruits bone cells and repairs fractures in early tests
Researchers in Brazil have developed a graphene-based scaffold derived from industrial waste that attracted bone cells and promoted fracture repair in laboratory and animal tests. The work, published ...
In two recent actions, the US Food and Drug Administration (FDA) issued warning letters to an eye implant manufacturer for a multitude of good manufacturing practice (GMP) violations and a biologics ...
A recent review is transforming the landscape of craniomaxillofacial bone regeneration with the introduction of personalized bioceramic grafts. This pioneering research explores the fabrication and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results